Drug Trial Radar · NCT02660944
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
Last checked: Nov 20, 2026Latest source record: Mar 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
64
Actual
Start
Jan 3, 2016
Primary completion
May 28, 2020
Study completion Aug 10, 2020
Sponsor
- Lead sponsor
- Resolve TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jan 21, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study evaluates the impact of 13 bi-weekly intravenous infusions of RSLV-132 on the cutaneous manifestations in subjects with systemic lupus erythematosus.
Conditions
- Systemic Lupus Erythematosus
Interventions
RSLV-132Drug
RNase-Fc fusion protein
PlaceboDrug
Saline placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) Improvement Compared to Placebo.Time frame: Baseline and Days 29, 57, 85, 99, 113, 127, 141, 155, 169
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
TriWest Research Associates
El Cajon, California
University of California San Diego
La Jolla, California
Valerius Research Center
Los Alamitos, California
Wallace Rheumatic Study Center
Los Angeles, California
University of Colorado
Aurora, Colorado
Clinical Research of West Florida
Clearwater, Florida
Center for Rheumatology, Immunology and Arthritis
Fort Lauderdale, Florida
Alper Research
Naples, Florida
Northwell Health/ Division of Rheumatology
Great Neck, New York
Feinstein Institute for Medical Research
Manhasset, New York
DJL Clinical Research
Charlotte, North Carolina
Cleveland Clinic
Cleveland, Ohio
Temple University
Philadelphia, Pennsylvania
Vanderbilt University
Nashville, Tennessee
Metroplex Clinical Research Center
Dallas, Texas
Accurate Clinical Research
Sugar Land, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.